Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,793,831
+$252,124 QoQ
Shares Held
30,688
-0.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1,270
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PHILADELPHIA TRUST CO holds $76,830,601 across 11 Drug Manufacturers - General names. JNJ ranks #3 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
150,654 | $37,910,572 | |
| 2 | AMGN |
Amgen Inc
|
36,796 | $13,324,567 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
30,688 | $7,793,831 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,416 | $6,735,456 | |
| 5 | LLY |
ELI LILLY & Co
|
3,859 | $4,628,600 | |
| 6 | GSK |
GSK plc
|
53,680 | $2,813,905 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,425 | $1,464,988 | |
| 8 | PFE |
Pfizer Inc
|
37,095 | $893,247 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,793,831 | 30,688 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,541,707 | 30,853 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,957,055 | 28,785 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,356,783 | 28,890 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,176,185 | 27,340 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,534,065 | 27,340 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,151,750 | 28,708 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,912,524 | 30,313 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,444,579 | 30,409 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,771,959 | 30,166 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,947,183 | 25,183 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,949,508 | 25,358 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,257,339 | 25,721 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $4,158,030 | 26,826 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,855,401 | 27,486 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,664,744 | 28,555 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,065,247 | 28,535 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,055,131 | 28,523 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $4,873,100 | 28,486 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,761,989 | 29,486 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,871,526 | 29,571 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,046,695 | 30,707 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,309,379 | 27,382 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,031,521 | 27,079 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,772,962 | 26,829 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,027,526 | 30,714 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||